Deep learning model reveals potential risk genes for ADHD, especially Ephrin receptor gene EPHA5.
Area Under Curve
Attention Deficit Disorder with Hyperactivity
/ diagnosis
Biomarkers
Computational Biology
/ methods
Deep Learning
Gene Ontology
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Linkage Disequilibrium
Polymorphism, Single Nucleotide
Quantitative Trait Loci
ROC Curve
Receptor, EphA5
/ genetics
ADHD identification
GWAS
deep learning
saliency map
Journal
Briefings in bioinformatics
ISSN: 1477-4054
Titre abrégé: Brief Bioinform
Pays: England
ID NLM: 100912837
Informations de publication
Date de publication:
05 11 2021
05 11 2021
Historique:
received:
04
03
2021
revised:
30
04
2021
accepted:
11
05
2021
pubmed:
11
6
2021
medline:
12
3
2022
entrez:
10
6
2021
Statut:
ppublish
Résumé
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder. Although genome-wide association studies (GWAS) identify the risk ADHD-associated variants and genes with significant P-values, they may neglect the combined effect of multiple variants with insignificant P-values. Here, we proposed a convolutional neural network (CNN) to classify 1033 individuals diagnosed with ADHD from 950 healthy controls according to their genomic data. The model takes the single nucleotide polymorphism (SNP) loci of P-values $\le{1\times 10^{-3}}$, i.e. 764 loci, as inputs, and achieved an accuracy of 0.9018, AUC of 0.9570, sensitivity of 0.8980 and specificity of 0.9055. By incorporating the saliency analysis for the deep learning network, a total of 96 candidate genes were found, of which 14 genes have been reported in previous ADHD-related studies. Furthermore, joint Gene Ontology enrichment and expression Quantitative Trait Loci analysis identified a potential risk gene for ADHD, EPHA5 with a variant of rs4860671. Overall, our CNN deep learning model exhibited a high accuracy for ADHD classification and demonstrated that the deep learning model could capture variants' combining effect with insignificant P-value, while GWAS fails. To our best knowledge, our model is the first deep learning method for the classification of ADHD with SNPs data.
Identifiants
pubmed: 34109382
pii: 6295376
doi: 10.1093/bib/bbab207
pmc: PMC8575025
pii:
doi:
Substances chimiques
Biomarkers
0
EPHA5 protein, human
EC 2.7.10.1
Receptor, EphA5
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press.
Références
J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):884-97
pubmed: 20732625
Am J Med Genet B Neuropsychiatr Genet. 2013 Jul;162B(5):419-430
pubmed: 23728934
Cold Spring Harb Protoc. 2009 Nov;2009(11):pdb.top62
pubmed: 20150074
World J Biol Psychiatry. 2012 Mar;13(3):211-22
pubmed: 21473668
Neuropsychopharmacology. 2015 Mar;40(4):915-26
pubmed: 25284319
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
IEEE Trans Med Imaging. 2016 May;35(5):1207-1216
pubmed: 26955021
Am J Med Genet A. 2013 Aug;161A(8):2078-83
pubmed: 23825006
Nat Protoc. 2011 Feb;6(2):121-33
pubmed: 21293453
Psychiatr Genet. 2019 Jun;29(3):86-90
pubmed: 30724859
Am J Psychiatry. 2006 Apr;163(4):716-23
pubmed: 16585449
Am J Hum Genet. 2019 Aug 1;105(2):334-350
pubmed: 31374203
PLoS One. 2013 Jul 12;8(7):e68095
pubmed: 23874508
Am J Psychiatry. 2011 Apr;168(4):365-77
pubmed: 21324949
J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):898-905.e3
pubmed: 20732626
Am J Med Genet B Neuropsychiatr Genet. 2016 Jul;171(5):733-47
pubmed: 27021288
Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1369-78
pubmed: 18951430
Genes Brain Behav. 2016 Feb;15(2):271-9
pubmed: 26560848
Nat Neurosci. 2014 Oct;17(10):1418-1428
pubmed: 25174004
Nat Genet. 2019 Nov;51(11):1637-1644
pubmed: 31676860
Nat Commun. 2018 May 29;9(1):2098
pubmed: 29844566
Mol Psychiatry. 2008 May;13(5):522-30
pubmed: 18301393
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
Int J Neuropsychopharmacol. 2013 Apr;16(3):549-56
pubmed: 22831755
Epilepsia. 2012 Sep;53(9):1526-38
pubmed: 22738016
Cureus. 2019 Jan 29;11(1):e3982
pubmed: 30967982
Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1345-54
pubmed: 18821565
Am J Med Genet B Neuropsychiatr Genet. 2015 Apr;168B(3):162-9
pubmed: 25739828
Am J Psychiatry. 2019 Mar 1;176(3):228-238
pubmed: 30818988
Nat Genet. 2019 Jan;51(1):63-75
pubmed: 30478444
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):146-151
pubmed: 27789541
eNeuro. 2017 Feb 6;4(1):
pubmed: 28197551
Transl Psychiatry. 2017 Aug 15;7(8):e1201
pubmed: 28809852
Mol Psychiatry. 2019 Apr;24(4):562-575
pubmed: 29892054
Am J Med Genet A. 2013 Aug;161A(8):1923-8
pubmed: 23824631
Nat Genet. 2018 Aug;50(8):1112-1121
pubmed: 30038396
J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):906-20
pubmed: 20732627
Nat Genet. 2019 Feb;51(2):245-257
pubmed: 30643258
Am J Med Genet A. 2007 Feb 15;143(4):343-8
pubmed: 17256793
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
Lancet Psychiatry. 2018 Feb;5(2):175-186
pubmed: 29033005
Curr Protoc Bioinformatics. 2014 Sep 08;47:1.24.1-19
pubmed: 25199789
Am J Hum Genet. 2013 Feb 7;92(2):221-37
pubmed: 23375656
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
J Neural Transm (Vienna). 2008 Nov;115(11):1573-85
pubmed: 18839057